Watson cleared to release Lysteda generic
Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for tranexamic acid tablets, a medication for menstrual bleeding. The company said Thursday that it will immediately begin shipping the product, which is a generic equivalent to Ferring Pharmaceuticals’ Lysteda.